বাংলায় দেখুন
Arlin

Arlin

Tablet

🧬 Linezolid 🏢 Beximco Pharmaceuticals Ltd.
Generic Name Linezolid
Manufacturer Beximco Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 85.00 (2 x 10: ৳ 1,700.00) Strip Price: ৳ 850.00

🔹 Indications

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Pharmacology

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Dosage & Administration

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Interaction

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Contraindications

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Side Effects

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Pregnancy & Lactation

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

🔹 Precautions & Warnings

Arlin is indicated for the treatment of:
  • Nosocomial pneumonia
  • Community-acquired pneumonia
  • Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis
  • Uncomplicated skin and skin structure infections
  • Vancomycin-resistant Enterococcus faecium infections
Limitations of use: Arlin is not indicated for the treatment of Gram-negative infections. The safety and efficacy of Arlin given for longer than 28 days have not been evaluated in controlled clinical trials.

💡 Frequently Asked Questions

Arlin is indicated for the treatment of: Nosocomial pneumonia Community-acquired pneumonia Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis Uncomplicated skin and skin structure infe...
Arlin is indicated for the treatment of: Nosocomial pneumonia Community-acquired pneumonia Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis Uncomplicated skin and skin structure infe...
Arlin is indicated for the treatment of: Nosocomial pneumonia Community-acquired pneumonia Complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis Uncomplicated skin and skin structure infe...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review